Cancer-related hypercalcemia is a major problem in clinical oncology. We recently showed that gallium nitrate directly inhibits in vitro bone resorption despite stimulation with parathyroid hormone and osteoclast activating factor. In a pilot study, we further demonstrated that this drug is effective treatment for cancer-related hypercalcemia. This application seeks to continue this area of clinical investigation. We plan to conduct two clinical studies: 1. Four dose-schedules of drug administration will establish a minimal effective dose for use in cancer-related hypercalcemia. Pharmacokinetics of gallium nitrate will also be studied in this trial to correlate hypocalcemic response with plasma drug concentrations. 2. When an optimal dose is established in the preceding study, we will conduct a prospective, randomized comparison of gallium nitrate vs. best standard treatment for patients with resistant cancer-related hypercalcemia. Our preliminary investigations have identified gallium nitrate as a compound with major effects upon calcium homeostasis. In this application, we expect to demonstrate that gallium nitrate is at least as effective as the best conventional treatment for cancer-related hypercalcemia and that it causes less toxicity. The results of these studies should significantly further the development of gallium nitrate for treatment of this indication.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA037768-02
Application #
3175574
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1984-07-01
Project End
1987-06-30
Budget Start
1985-07-01
Budget End
1987-06-30
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Memorial Hospital for Cancer & Allied Di
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10021
Warrell Jr, R P; Bockman, R S (1989) Gallium in the treatment of hypercalcemia and bone metastasis. Important Adv Oncol :205-20
Repo, M A; Bockman, R S; Betts, F et al. (1988) Effect of gallium on bone mineral properties. Calcif Tissue Int 43:300-6
Warrell Jr, R P; Israel, R; Frisone, M et al. (1988) Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin. Ann Intern Med 108:669-74
Warrell Jr, R P; Issacs, M; Alcock, N W et al. (1987) Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma. Ann Intern Med 107:683-6
Warrell Jr, R P; Skelos, A; Alcock, N W et al. (1986) Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicopharmacological and dose response analysis. Cancer Res 46:4208-12
Bockman, R S; Boskey, A L; Blumenthal, N C et al. (1986) Gallium increases bone calcium and crystallite perfection of hydroxyapatite. Calcif Tissue Int 39:376-81